DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH FY 2022 CONGRESSIONAL JUSTIFICATION Significant Items Page No. 7q11.23 Duplication Syndrome ...................................................................................................... 4 Academic and Non-Profit Institutional Research Using Human Ocular Tissue from Not-for- Profit Eye Banks ............................................................................................................................. 6 Addressing Maternal Mortality Disparities .................................................................................... 8 Addressing Youth Mental Health Disparities ............................................................................... 10 Alzheimer’s Disease and Dementia Screening Tools ................................................................... 12 Amyloidosis .................................................................................................................................. 14 Amyotrophic Lateral Sclerosis ..................................................................................................... 16 Antimicrobial Resistance .............................................................................................................. 17 Biomedical Research Facilities ..................................................................................................... 19 BRAIN Initiative ........................................................................................................................... 21 Building and Facilities (B&F) ...................................................................................................... 23 Cancer Immunotherapy ................................................................................................................. 25 Celiac Disease ............................................................................................................................... 27 Childhood Cancer Data Initiative (CCDI) .................................................................................... 29 Childhood Cancer Survival Metrics.............................................................................................. 31 Childhood Post-Infectious Autoimmune Disorders ...................................................................... 33 Clinical and Translational Science Awards (CTSA) .................................................................... 35 Deadliest Cancers.......................................................................................................................... 37 Deadliest Cancers - Updates on Seven Deadliest Cancers ........................................................... 40 Diabetes......................................................................................................................................... 45 Dystonia ........................................................................................................................................ 47 Eating Disorder Research ............................................................................................................. 49 Environmental influences on Child Health Outcomes (ECHO) ................................................... 51 E-Cigarette Research .................................................................................................................... 54 Endometrial Cancer ...................................................................................................................... 56 1 Federal Advisory Committees Transparency Initiative ................................................................ 58 Fetal Tissue ................................................................................................................................... 60 Gastric Cancer ............................................................................................................................... 61 Glioblastoma (GBM) .................................................................................................................... 63 Government-wide Collaborations ................................................................................................. 64 Hereditary Spastic Paraparesis 49 (TECPR2)............................................................................... 66 Induced Pluripotent Stem Cell (iPSC) Technology ...................................................................... 68 Inflammatory Bowel Diseases (IBD)............................................................................................ 70 Liver Cancer.................................................................................................................................. 72 Macular Degeneration ................................................................................................................... 74 Male Reproductive Health ............................................................................................................ 76 Maternal Mortality Research ........................................................................................................ 78 Maternal-Fetal Medicine Units (MFMU) Network ...................................................................... 80 Melanoma ..................................................................................................................................... 82 Mitochondrial Disease Research Coordination ............................................................................ 85 Multiple Sulfatase Deficiency (MSD) .......................................................................................... 87 Myotonic Dystrophy ..................................................................................................................... 89 National Commission on Lymphatic Diseases ............................................................................. 91 Office of Cancer Survivorship ...................................................................................................... 93 Pediatric Cancer ............................................................................................................................ 94 Pediatric Nephrology .................................................................................................................... 97 Pediatric Research ......................................................................................................................... 99 Pelvic Floor Disorder .................................................................................................................. 101 Polycystic Ovary Syndrome (PCOS, NICHD) ........................................................................... 103 Polycystic Ovary Syndrome (PCOS, NHLBI)............................................................................ 105 Premature Births ......................................................................................................................... 107 Primate Research ........................................................................................................................ 110 Psychosocial Distress Complications ......................................................................................... 113 RADx .......................................................................................................................................... 115 Rare Cancers Therapeutics Research and Development – DART Study ................................... 118 Rare Cancer Therapeutic Research and Development ................................................................ 121 2 Research in Pregnant and Lactating Women .............................................................................. 124 Sickle Cell Disease (SCD) .......................................................................................................... 126 Spina Bifida ................................................................................................................................ 128 STAR Act.................................................................................................................................... 130 Suicide Prevention ...................................................................................................................... 132 Surveillance, Epidemiology, and End Results (SEER) Program Registry ................................. 134 Swine Research ........................................................................................................................... 136 Temporomandibular Disorders (TMD)....................................................................................... 138 Thalassemia (NIA) ...................................................................................................................... 140 Thalassemia (NHLBI) ................................................................................................................. 142 Traumatic Brain Injury ............................................................................................................... 144 Women and Lung Cancer ........................................................................................................... 146 Women’s Health Research Priorities .......................................................................................... 148 Women's Health .........................................................................................................................